You have 9 free searches left this month | for more free features.

prexasertib

Showing 1 - 14 of 14

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Desmoplastic Small Round Cell Tumor, Rhabdomyosarcoma Trial in New York (Prexasertib, Irinotecan)

Active, not recruiting
  • Desmoplastic Small Round Cell Tumor
  • Rhabdomyosarcoma
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Oct 3, 2022

Solid Tumor Trial in Boston (Prexasertib, Olaparib)

Completed
  • Solid Tumor
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Sep 1, 2021

Cancer Trial in Boston (LY3300054, Prexasertib)

Completed
  • Cancer
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Apr 13, 2021

Brain Tumor, Brain Tumor, Recurrent, Brain Tumor, Refractory Trial in Memphis (Prexasertib, Cyclophosphamide, Gemcitabine)

Active, not recruiting
  • Brain Tumor
  • +12 more
  • Prexasertib
  • +4 more
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
Oct 20, 2022

Ovarian Cancer Trial in Worldwide (Prexasertib)

Completed
  • Ovarian Cancer
  • Prexasertib
  • Tucson, Arizona
  • +45 more
Sep 28, 2021

Childhood Solid Tumor, Recurrent Malignant Solid Tumor, Recurrent Primary CNS Tumor Trial in United States (Laboratory Biomarker

Completed
  • Childhood Solid Neoplasm
  • +4 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Birmingham, Alabama
  • +20 more
Apr 12, 2021

Tumor Metastasis, Colorectal Tumors, Breast Cancer Trial in United States (Prexasertib, Cisplatin, Cetuximab)

Completed
  • Neoplasm Metastasis
  • +2 more
  • Prexasertib
  • +7 more
  • Sarasota, Florida
  • +4 more
Mar 30, 2020

Advanced Cancer Trial in Liverpool ([¹4C]Prexasertib, Prexasertib)

Completed
  • Advanced Cancer
  • Liverpool, United Kingdom
    For additional information regarding investigative sites for thi
Jul 30, 2019

Acute Myeloid Leukemia, MDS Trial in Boston (Prexasertib, Mitoxantrone, Etoposide)

Terminated
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndromes
  • Prexasertib
  • +3 more
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Jun 10, 2019

Head and Neck Tumors Trial in France, United States (Prexasertib, Cisplatin, Cetuximab)

Completed
  • Head and Neck Neoplasms
  • Prexasertib
  • +3 more
  • Birmingham, Alabama
  • +3 more
Feb 12, 2019

Advanced Cancer, Metastatic Cancer, Colorectal Cancer Trial in Charlotte, Nashville, Köln (prexasertib, ralimetinib)

Completed
  • Advanced Cancer
  • +3 more
  • Charlotte, North Carolina
  • +2 more
Dec 12, 2018

Small Cell Lung Cancer Trial in Worldwide (Prexasertib)

Completed
  • Small Cell Lung Cancer
  • Prexasertib
  • Fayetteville, Arkansas
  • +40 more
Mar 12, 2020

Tumor Trial in Chiba, Tokyo (Prexasertib)

Completed
  • Neoplasm
  • Prexasertib
  • Chiba, Japan
  • +1 more
May 19, 2017

Advanced Cancer, Squamous Cell Carcinoma, Carcinoma, Squamous Cell of Head and Neck Trial in United States (Prexasertib)

Completed
  • Advanced Cancer
  • +5 more
  • Prexasertib
  • Sarasota, Florida
  • +4 more
May 9, 2016